EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CRP and sCD25 help distinguish between adult‐onset Still's disease and HLH

Madelaine Beckett iD, Caroline Spaner iD, Mariam Goubran iD, John Wade, Juan Antonio Avina-Zubieta iD, Audi Setiadi iD, Lori Tucker iD, Kam Shojania iD, Sheila Au, Andre Mattman iD, Agnes Y Y Lee iD, David C Fajgenbaum iD und 1 weitere

European Journal of Haematology · 2024

DOI: 10.1111/ejh.14267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Madelaine Beckett und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Still's Disease, Adult-Onset, Lymphohistiocytosis, Hemophagocytic, Biomarkers, Interleukin-2 Receptor alpha Subunit. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Adult‐onset Still's disease (AOSD) and secondary hemophagocytic lymphohistiocytosis (sHLH) are both hyperferritinemic cytokine storm syndromes that can be difficult to distinguish from each other in hospitalized patients. The objective of this study was to compare the inflammatory markers ferritin, D‐dimer, C‐reactive protein (CRP), and soluble CD25 (sCD25) in patients with AOSD and sHLH. These four markers were chosen as they are widely available and represent different aspects of inflammatory diseases: macrophage activation (ferritin); endothelialopathy (D‐dimer); interleukin‐1/interleukin‐6/tumour necrosis factor elevation (CRP) and T cell activation (sCD25).

Methods

This was a single‐center retrospective study. Patients diagnosed by the Hematology service at Vancouver General Hospital for AOSD or sHLH from 2009 to 2023 were included.

Results

There were 16 AOSD and 44 sHLH patients identified. Ferritin was lower in AOSD than HLH (median 11 360 μg/L vs. 29 020 μg/L, p = .01) while D‐dimer was not significantly different (median 5310 mg/L FEU vs. 7000 mg/L FEU, p = .3). CRP was higher (median 168 mg/L vs. 71 mg/L, p 130 mg/L and sCD25< 3900 U/mL to distinguish AOSD from HLH had an area under the curve (AUC) of 0.94 (95% confidence interval 0.93–0.97) with sensitivity 91% and specificity 93%.

Conclusions

These findings suggest that simple, widely available laboratory tests such as CRP and sCD25 can help clinicians distinguish AOSD from HLH in acutely ill adults with extreme hyperferritinemia. Larger studies examining a wider range of clinically available inflammatory biomarkers in a more diverse set of cytokine storm syndromes are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Still's Disease, Adult-OnsetLymphohistiocytosis, HemophagocyticBiomarkersInterleukin-2 Receptor alpha SubunitC-Reactive ProteinHumansMaleFemaleAdultDiagnosis, DifferentialMiddle AgedRetrospective StudiesROC CurveFerritinsAgedFibrin Fibrinogen Degradation Products

Stichwörter der Autor:innen

HLHStill's diseaseautoinflammatorycytokine stormsoluble IL‐2 receptor

Substanzen

BiomarkersInterleukin-2 Receptor alpha SubunitC-Reactive ProteinFerritinsFibrin Fibrinogen Degradation ProductsIL2RA protein, humanfibrin fragment D

Autor:innen und Institutionen

  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Division of Hematopathology, British Columbia Children's Hospital, Vancouver, Canada.
  • Division of Pediatric Rheumatology, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada.
  • Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.

ORCID-Profile: Madelaine Beckett, Caroline Spaner, Mariam Goubran, Juan Antonio Avina-Zubieta, Audi Setiadi, Lori Tucker, Kam Shojania, Andre Mattman, Agnes Y Y Lee, David C Fajgenbaum, Luke Y C Chen

Zitieren

APA

Beckett, M., Spaner, C., Goubran, M., Wade, J., Avina-Zubieta, J. A., Setiadi, A., Tucker, L., Shojania, K., Au, S., Mattman, A., Lee, A. Y. Y., Fajgenbaum, D. C., & Chen, L. Y. C. (2024). CRP and sCD25 help distinguish between adult‐onset Still's disease and HLH. European Journal of Haematology. https://doi.org/10.1111/ejh.14267

Vancouver

Beckett M, Spaner C, Goubran M, Wade J, Avina-Zubieta JA, Setiadi A, et al. CRP and sCD25 help distinguish between adult‐onset Still's disease and HLH. European Journal of Haematology. 2024. doi:10.1111/ejh.14267

BibTeX
@article{Beckett2024,
  author = {Beckett, Madelaine and Spaner, Caroline and Goubran, Mariam and Wade, John and Avina-Zubieta, Juan Antonio and Setiadi, Audi and Tucker, Lori and Shojania, Kam and Au, Sheila and Mattman, Andre and Lee, Agnes Y Y and Fajgenbaum, David C and Chen, Luke Y C},
  title = {CRP and sCD25 help distinguish between adult‐onset Still's disease and HLH},
  journal = {European Journal of Haematology},
  year = {2024},
  doi = {10.1111/ejh.14267}
}
Kostenlos starten →